The Trump administration has temporarily waived telehealth restrictions for Medicare, which means more Medicare patients can access certain health care services from their homes during the #COVID19 crisis. Learn what this means for beneficiaries with kidney disease READ MORE >>

As part of the 21st Century Cures Act that was signed into law in 2016, all beneficiaries who qualify for Medicare due to ESRD will have the option to receive their coverage through a private MA plan, starting with the 2021 plan year. READ MORE >>

As the Trump Administration moves to implement its Advancing American Kidney Health initiative, it has asked for input from patient organizations like the American Kidney Fund (AKF). We submitted comments on two recent proposals from the Administration that are intended to increase the number of kidneys available for transplant. READ MORE >>

Kathy Mitchell caught her kidney disease early and has not had to start dialysis. She is currently the Director of Government Affairs for Root Insurance. READ MORE >>

Update March 12, 2020: H.R. 5534 passed unanimously in the House Energy and Commerce Health Subcommittee on March 11. Extended Medicare coverage of immunosuppressive drugs will help kidney recipients avoid situations where they struggle to pay for their needed medications and other necessities. READ MORE >>

Amy Walker is a living kidney donor to her father. She donated two years ago and says she would do it again in a heartbeat. READ MORE >>

Ken Sutha, who was honored as AKF’s 2019 Hero of Hope, was first diagnosed with kidney disease at 10 years old. He received a transplant from his father in 2006, which lasted for 10 years, and got his second transplant in July 2018. Dr. Sutha currently works as a pediatric nephrologist and an organoid researcher. READ MORE >>

Dean is a retired Branch Manager for Canon Business Solutions. Before, and since retiring in Feb 2018, he was involved with Bladder Cancer Action Network as a patient advocate receiving PCORI training and working with pharmaceutical companies providing the patients perspective as new cancer therapies are developed and readied for market. READ MORE >>